A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma

Peer Review reports

Original Submission
24 Dec 2012	Submitted	Original manuscript
7 Mar 2013	Reviewed	Reviewer Report - Leonard Bielory
11 Mar 2013	Reviewed	Reviewer Report - Bradley Chipps
12 Apr 2013	Author responded	Author comments - Kevin Murphy
Resubmission - Version 2
12 Apr 2013	Submitted	Manuscript version 2
Publishing
10 May 2013	Editorially accepted
1 Jun 2013	Article published	10.1186/1477-5751-12-10

Back to article page